mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for FOXP2
Gene summary
Basic gene Info.Gene symbolFOXP2
Gene nameforkhead box P2
SynonymsCAGH44|SPCH1|TNRC10
CytomapUCSC genome browser: 7q31
Type of geneprotein-coding
RefGenesNM_001172766.2,
NM_001172767.2,NM_014491.3,NM_148898.3,NM_148899.3,
NM_148900.3,NR_033766.1,NR_033767.1,
DescriptionCAG repeat protein 44forkhead box protein P2forkhead/winged-helix transcription factortrinucleotide repeat containing 10trinucleotide repeat-containing gene 10 protein
Modification date20141207
dbXrefs MIM : 605317
HGNC : HGNC
Ensembl : ENSG00000128573
HPRD : 05611
Vega : OTTHUMG00000023131
ProteinUniProt: O15409
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FOXP2
BioGPS: 93986
PathwayNCI Pathway Interaction Database: FOXP2
KEGG: FOXP2
REACTOME: FOXP2
Pathway Commons: FOXP2
ContextiHOP: FOXP2
ligand binding site mutation search in PubMed: FOXP2
UCL Cancer Institute: FOXP2
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0045892negative regulation of transcription, DNA-templated18987363


Top
Ligand binding site mutations for FOXP2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R543R543CBLCA1
R542,Y540F541LHNSC1
L556,H554N555SLUSC1
R543N544ILUSC1
H559H559POV1
R327R328QSKCM1
F507P506LSKCM1
Y509Y509DSKCM1
A539T537ASTAD1
R32D33NUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for FOXP2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H559H559P-1.1519723
A539T537A-0.8878537
R327R328Q-0.77936344
F507P506L-0.69327023
Y509Y509D-0.58896128
R543R543C-0.53981053
R32D33N-0.52252601
H554N555S-0.47017164
L556N555S-0.47017164
R543N544I-0.14145286
Y540F541L-0.12351641
R542F541L-0.12351641
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for FOXP2 from PDB

Top
Differential gene expression and gene-gene network for FOXP2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of FOXP2 and the right PPI network was created from samples without mutations in the LBS of FOXP2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for FOXP2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0750927Developmental verbal dyspraxia14Biomarker, GeneticVariation
umls:C0004352Autistic Disorder12Biomarker, GeneticVariation
umls:C0003635Apraxias3Biomarker
umls:C0175693Silver-Russell Syndrome1Biomarker
umls:C0010606Carcinoma, Adenoid Cystic1Biomarker
umls:C0376634Craniofacial Abnormalities1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for FOXP2
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of FOXP2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids2a07JA539 R542
NUCNucleic Acids2a07KA539 R542
NUCNucleic Acids2as5FF507 Y509
NUCNucleic Acids2a07JH554
NUCNucleic Acids2a07KH554
NUCNucleic Acids2as5FH554
NUCNucleic Acids2as5GH554
MGMAGNESIUM(2+)2a07FH559
MGMAGNESIUM(2+)2a07IH559
MGMAGNESIUM(2+)2a07GL556 H559
MGMAGNESIUM(2+)2a07HL556 H559
MGMAGNESIUM(2+)2a07JL556 H559
MGMAGNESIUM(2+)2a07KL556 H559
MGMAGNESIUM(2+)2as5FL556 H559
MGMAGNESIUM(2+)2as5GL556 H559
NUCNucleic Acids2a07JR543
NUCNucleic Acids2a07KR543
NUCNucleic Acids2a07GY509
NUCNucleic Acids2a07HY509
NUCNucleic Acids2as5GY509
NUCNucleic Acids2a07JY509 H554
NUCNucleic Acids2a07KY509 H554
NUCNucleic Acids2a07FY540 R543 H554
NUCNucleic Acids2a07IY540 R543 H554


Top
Conservation information for LBS of FOXP2
Multiple alignments for O15409 in multiple species
LBSAA sequence# speciesSpecies
A539FTRTFAYFRRN3Homo sapiens, Rattus norvegicus, Pan troglodytes
A571ENVKGAVWTVD3Homo sapiens, Rattus norvegicus, Pan troglodytes
F507DVRPPFTYATL3Homo sapiens, Rattus norvegicus, Pan troglodytes
F562SLHKCFVRVEN3Homo sapiens, Rattus norvegicus, Pan troglodytes
H554KNAVRHNLSLH3Homo sapiens, Rattus norvegicus, Pan troglodytes
H559HNLSLHKCFVR3Homo sapiens, Rattus norvegicus, Pan troglodytes
K560NLSLHKCFVRV3Homo sapiens, Rattus norvegicus, Pan troglodytes
L527DRQLTLNEIYS3Homo sapiens, Rattus norvegicus, Pan troglodytes
L556AVRHNLSLHKC3Homo sapiens, Rattus norvegicus, Pan troglodytes
L558RHNLSLHKCFV3Homo sapiens, Rattus norvegicus, Pan troglodytes
N550AATWKNAVRHN3Homo sapiens, Rattus norvegicus, Pan troglodytes
R32LDAGSRDGRSS3Homo sapiens, Rattus norvegicus, Pan troglodytes
R327SVLNARRDSSS2Rattus norvegicus, Pan troglodytes
R327SVLSARRDSSS1Homo sapiens
R504KNADVRPPFTY3Homo sapiens, Rattus norvegicus, Pan troglodytes
R542TFAYFRRNAAT3Homo sapiens, Rattus norvegicus, Pan troglodytes
R543FAYFRRNAATW3Homo sapiens, Rattus norvegicus, Pan troglodytes
R553WKNAVRHNLSL3Homo sapiens, Rattus norvegicus, Pan troglodytes
R564HKCFVRVENVK3Homo sapiens, Rattus norvegicus, Pan troglodytes
S557VRHNLSLHKCF3Homo sapiens, Rattus norvegicus, Pan troglodytes
T508VRPPFTYATLI3Homo sapiens, Rattus norvegicus, Pan troglodytes
T547RRNAATWKNAV3Homo sapiens, Rattus norvegicus, Pan troglodytes
V503YKNADVRPPFT3Homo sapiens, Rattus norvegicus, Pan troglodytes
W573VKGAVWTVDEV3Homo sapiens, Rattus norvegicus, Pan troglodytes
Y509RPPFTYATLIR3Homo sapiens, Rattus norvegicus, Pan troglodytes
Y531TLNEIYSWFTR3Homo sapiens, Rattus norvegicus, Pan troglodytes
Y540TRTFAYFRRNA3Homo sapiens, Rattus norvegicus, Pan troglodytes


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas